AV7909 Formulation 3: Clinical Trials

1 trial of AV7909 Formulation 3, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow AV7909 Formulation 3: new trials by email Literature Review of AV7909 Formulation 3 trials Research Report on AV7909 Formulation 3

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety, Tolerability and Immunogenicity Study of AV7909 Anthrax Vaccine in Healthy Adults
BioThrax, AV7909 Formulation 1, AV7909 Formulation 2 - Bacillus Anthracis (Anthrax) Infection
Phase 1CompletedEmergent BioSolutions1052010-12-012024-03-18

Conditions studied

Anthrax (1)  ·  Infections (1)

Sponsors

Emergent BioSolutions (1)

Countries

United States (1)

Top investigators

Edward Bernton, MD (1)

Results publications

PMID 23701746